Parallel synthesis and cytotoxicity evaluation of a polyamine-quinone conjugates library

Journal of Medicinal Chemistry

Volumn 51, Issue 17, 2008, Pages 5463-5467

  Bolognesi, Maria Laura ^a   Calonghi, Natalia ^a   Mangano, Chiara ^a   Masotti, Lanfranco ^a   Melchiorre, Carlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FR 18; POLYAMINE; QUINONE DERIVATIVE; SIGNAL PEPTIDE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; LIBRARY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; HT29 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; POLYAMINES; QUINONES; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 51849128290     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800637b     Document Type: Article

References (37)

1. Lloyd, D. G.; Golfis, G.; Knox, A. J.; Fayne, D.; Meegan, M. J.; Oprea, T. I. Oncology exploration: charting cancer medicinal chemistry space. Drug Discovery Today 2006, 11, 149-159.
2. Koehn, F. E.; Carter, G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discovery 2005, 4, 206-220.
3. Noren-Muller, A.; Reis-Correa, I., Jr.; Prinz, H.; Rosenbaum, C.; Saxena, K.; Schwalbe, H. J.; Vestweber, D.; Cagna, G.; Schunk, S.; Schwarz, O.; Schiewe, H.; Waldmann, H. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 10606-10611.
4. Koch, M. A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277.
5. Tan, G.; Gyllenhaal, C.; Soejarto, D. D. Biodiversity as a source of anticancer drugs. Curr. Drug Targets 2006, 7, 265-277.
6. Clardy, J.; Walsh, C. Lessons from natural molecules. Nature 2004, 432, 829-837.
7. Simmons, T. L.; Andrianasolo, E.; McPhail, K.; Flatt, P.; Gerwick, W. H. Marine natural products as anticancer drugs. Mol. Cancer Ther. 2005, 4, 333-342.
8. Ichikawa, H.; Nakamura, Y.; Kashiwada, Y.; Aggarwal, B. B. Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr. Pharm. Des. 2007, 13, 3400-3416.
9. Altmann, K. H.; Gertsch, J. Anticancer drugs from nature: natural products as a unique source of new microtubule-stabilizing agents. Nat. Prod. Rep. 2007, 24, 327-357.
10. Newman, D. J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery. J. Med. Chem. 2008, 51, 2589-2599.
11. Verma, R. P. Anti-cancer activities of 1,4-naphthoquinones: a QSAR study. Anticancer Agents Med. Chem. 2006, 6, 489-499.
12. Huang, Q.; Lu, G.; Shen, H. M.; Chung, M. C.; Ong, C. N. Anticancer properties of anthraquinones from rhubarb. Med. Res. Rev. 2007, 27, 609-630.
13. Hua, D. H.; Lou, K.; Battina, S. K.; Zhao, H.; Perchellet, E. M.; Wang, Y.; Perchellet, J. P. Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs. Anticancer Agents Med. Chem. 2006, 6, 303-318.
14. Ravelo, A. G.; Estevez-Braun, A.; Chavez-Orellana, H.; Perez-Sacau, E.; Mesa.Siverio, D. Recent studies on natural products as anticancer agents. Curr. Top. Med. Chem. 2004, 4, 241-265.
15. Garuti, L.; Roberti, M.; Pizzirani, D. Nitrogen-containing heterocyclic quinones: a class of potential selective antitumor agents. Mini Rev. Med. Chem. 2007, 7, 481-489.
16. Kwak, H. J.; Park, M. J.; Park, C. M.; Moon, S. I.; Yoo, D. H.; Lee, H. C.; Lee, S. H.; Kim, M. S.; Lee, H. W.; Shin, W. S.; Park, I. C.; Rhee, C. H.; Hong, S. I. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int. J. Cancer 2006, 118, 2711-2720.
17. Nakaya, K.; Miyasaka, T. A shikonin derivative, beta- hydroxyisovalerylshikonin, is an ATP-noncompetitive inhibitor of protein tyrosine kinases. Anticancer Drugs 2003, 14, 683-693.
18. Liao, J. J. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J. Med. Chem. 2007, 50, 409-424.
19. Casero, R. A., Jr.; Marton, L. J. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug Discovery 2007, 6, 373390.
20. Seller, N. Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol. Ther. 2005, 107, 99-119.
21. Flamigni, F.; Stanic, I.; Facchini, A.; Cetrullo, S.; Tantini, B.; Borzi, R. M.; Guarnieri, C.; Caldarera, C. M. Polyamine biosynthesis as a target to inhibit apoptosis of nontumoral cells. Amino Acids 2007, 33, 197-202.
22. Calonghi, N.; Pagnotta, E.; Parolin, C.; Mangano, C.; Bolognesi, M. L.; Melchiorre, C.; Masotti, L. A new EGFR inhibitor induces apoptosis in colon cancer cells. Biochem. Biophys. Res. Commun. 2007, 354, 409-413.
23. Kissau, L.; Stahl, P.; Mazitschek, R.; Giannis, A.; Waldmann, H. Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold. J. Med. Chem. 2003, 46, 2917-2931.
24. Finley, K. T. Quinones: the present state of addition and substitution chemistry. In The Chemistry of Hydroxyl, Ether and Peroxide Groups.; Patai, S. Ed.; John Wiley: Chichester, 1993; pp 1027-1034.
25. Cunha, A. S.; Lima, E. L. S.; Pinto, A. C.; Esteves-Souza, A.; Echevarria, A.; Camara, C. A.; Vargas, M. D.; Torres, J. C. Synthesis of novel naphthoquinone-spermidine conjugates and their effects on DNA-topoisomerases 1 and II-a. J. Braz. Chem. Soc. 2006, 17, 439-442.
26. Nagarajan, M.; Xiao, X.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen. J. Med. Chem. 2003, 46, 5712-5724.
27. Hu, W. L.; Hesse, M. Synthese der p-cumaroylspermidine. Helv. Chim. Acta 1996, 79, 548-559.
28. Wellendorph, P.; Jaroszewski, J. W.; Hansen, S. H.; Franzyk, H. A sequential high-yielding large-scale solution: method for synthesis of philanthotoxin analogues. Eur. J. Med. Chem. 2003, 38, 117-122.
29. Nakanishi, K.; Huang, X.; Jiang, H.; Liu, Y.; Fang, K.; Huang, D.; Choi, S. K.; Katz, E.; Eldefrawi, M. Structure-binding relation of philanthotoxins from nicotinic acetylcholine receptor binding assay. Bioorg. Med. Chem. 1997, 5, 1969-1988.
30. Krapcho, A. P.; Kuell, C. S. Monoprotected diamines. N-tert-butoxycarbonyl-α,ω-alkanediamines from α,ω- alkanediamines. Synth. Commun. 1990, 20, 2559-2564.
31. Cullis, P. M.; Green, R. E.; Merson.Davies, L.; Travis, N. Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells. Chem. Biol. 1999, 6, 717-729.
32. Wang, C.; Delcros, J. G.; Biggerstaff, J.; Phanstiel, O. IV Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates. J. Med. Chem. 2003, 46, 2672-2682.
33. Olsen, J.; Overvad, K. The concept of multifactorial etiology of cancer. Pharmacol. Toxicol. 1993, 72 (1), 33-38.
34. Kamb, A.; Wee, S.; Lengauer, C. Why is cancer drug discovery so difficult? Nat. Rev. Drug Discovery 2007, 6, 115-120.
35. Sartore-Bianchi, A.; Ricotta, R.; Cerea, G.; Maugeri, M. R.; Siena, S. Rationale and clinical results of multitarget treatments in oncology. Int. J. Biol. Markers 2007, 22, S77-S87.
36. Cavalli, A.; Bolognesi, M. L.; Minarini, A.; Rosini, M.; Tumiatti, V.; Recanatini, M.; Melchiorre, C. Multitarget-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 2008, 51, 347-372.
37. Morphy, R.; Rankovic, Z. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 2005, 48, 6523-6543.